CHAPTER NO. 1 : INTRODUCTION 22
1.1.1. Report Description 22
Purpose of the Report 22
USP & Key Offerings 22
1.1.2. Key Benefits for Stakeholders 22
1.1.3. Target Audience 23
1.1.4. Report Scope 23
CHAPTER NO. 2 : EXECUTIVE SUMMARY 24
2.1. Venous Thromboembolism (VTE) Treatment Market Snapshot 24
2.1.1. Global Venous Thromboembolism (VTE) Treatment Market, 2018 – 2032 (USD Million) 26
CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS 27
3.1. Russia-Ukraine and Israel-Palestine War Impacts 27
CHAPTER NO. 4 : VENOUS THROMBOEMBOLISM (VTE) TREATMENT MARKET – INDUSTRY ANALYSIS 28
4.1. Introduction 28
4.2. Market Drivers 29
4.2.1. Driving Factor 1 Analysis 29
4.2.2. Driving Factor 2 Analysis 30
4.3. Market Restraints 31
4.3.1. Restraining Factor Analysis 31
4.4. Market Opportunities 32
4.4.1. Market Opportunity Analysis 32
4.5. Porter’s Five Forces Analysis 33
CHAPTER NO. 5 : ANALYSIS COMPETITIVE LANDSCAPE 34
5.1. Company Market Share Analysis – 2023 34
5.1.1. Global Venous Thromboembolism (VTE) Treatment Market: Company Market Share, by Volume, 2023 34
5.1.2. Global Venous Thromboembolism (VTE) Treatment Market: Company Market Share, by Revenue, 2023 35
5.1.3. Global Venous Thromboembolism (VTE) Treatment Market: Top 6 Company Market Share, by Revenue, 2023 35
5.1.4. Global Venous Thromboembolism (VTE) Treatment Market: Top 3 Company Market Share, by Revenue, 2023 36
5.2. Global Venous Thromboembolism (VTE) Treatment Market Company Volume Market Share, 2023 37
5.3. Global Venous Thromboembolism (VTE) Treatment Market Company Revenue Market Share, 2023 38
5.4. Company Assessment Metrics, 2023 39
5.4.1. Stars 39
5.4.2. Emerging Leaders 39
5.4.3. Pervasive Players 39
5.4.4. Participants 39
5.5. Start-ups /SMEs Assessment Metrics, 2023 39
5.5.1. Progressive Companies 39
5.5.2. Responsive Companies 39
5.5.3. Dynamic Companies 39
5.5.4. Starting Blocks 39
5.6. Strategic Developments 40
5.6.1. Acquisitions & Mergers 40
New Product Launch 40
Global Expansion 40
5.7. Key Players Product Matrix 41
CHAPTER NO. 6 : PESTEL & ADJACENT MARKET ANALYSIS 42
6.1. PESTEL 42
6.1.1. Political Factors 42
6.1.2. Economic Factors 42
6.1.3. Social Factors 42
6.1.4. Technological Factors 42
6.1.5. Environmental Factors 42
6.1.6. Legal Factors 42
6.2. Adjacent Market Analysis 42
CHAPTER NO. 7 : VENOUS THROMBOEMBOLISM (VTE) TREATMENT MARKET – BY TYPE SEGMENT ANALYSIS 43
7.1. Venous Thromboembolism (VTE) Treatment Market Overview, by Type Segment 43
7.1.1. Venous Thromboembolism (VTE) Treatment Market Revenue Share, By Type, 2023 & 2032 44
7.1.2. Venous Thromboembolism (VTE) Treatment Market Attractiveness Analysis, By Type 45
7.1.3. Incremental Revenue Growth Opportunity, by Type, 2024 – 2032 45
7.1.4. Venous Thromboembolism (VTE) Treatment Market Revenue, By Type, 2018, 2023, 2027 & 2032 46
7.2. Deep Vein Thrombosis 47
7.3. Pulmonary Embolism 48
7.4. Others 49
CHAPTER NO. 8 : VENOUS THROMBOEMBOLISM (VTE) TREATMENT MARKET – BY TREATMENT SEGMENT ANALYSIS 50
8.1. Venous Thromboembolism (VTE) Treatment Market Overview, by Treatment Segment 50
8.1.1. Venous Thromboembolism (VTE) Treatment Market Revenue Share, By Treatment, 2023 & 2032 51
8.1.2. Venous Thromboembolism (VTE) Treatment Market Attractiveness Analysis, By Treatment 52
8.1.3. Incremental Revenue Growth Opportunity, by Treatment, 2024 – 2032 52
8.1.4. Venous Thromboembolism (VTE) Treatment Market Revenue, By Treatment, 2018, 2023, 2027 & 2032 53
8.2. Mechanical Devices 54
8.3. Thrombolytic Therapy 55
8.4. Anti-Clotting Medications 56
8.5. Others 57
CHAPTER NO. 9 : VENOUS THROMBOEMBOLISM (VTE) TREATMENT MARKET – BY END-USER SEGMENT ANALYSIS 58
9.1. Venous Thromboembolism (VTE) Treatment Market Overview, by End-user Segment 58
9.1.1. Venous Thromboembolism (VTE) Treatment Market Revenue Share, By End-user, 2023 & 2032 59
9.1.2. Venous Thromboembolism (VTE) Treatment Market Attractiveness Analysis, By End-user 60
9.1.3. Incremental Revenue Growth Opportunity, by End-user, 2024 – 2032 60
9.1.4. Venous Thromboembolism (VTE) Treatment Market Revenue, By End-user, 2018, 2023, 2027 & 2032 61
9.2. Homecare 62
9.3. Speciality Centres 63
9.4. Hospitals 64
9.5. Others 65
CHAPTER NO. 10 : VENOUS THROMBOEMBOLISM (VTE) TREATMENT MARKET – BY DISTRIBUTION CHANNEL SEGMENT ANALYSIS 66
10.1. Venous Thromboembolism (VTE) Treatment Market Overview, by Distribution Channel Segment 66
10.1.1. Venous Thromboembolism (VTE) Treatment Market Revenue Share, By Distribution Channel, 2023 & 2032 67
10.1.2. Venous Thromboembolism (VTE) Treatment Market Attractiveness Analysis, By Distribution Channel 68
10.1.3. Incremental Revenue Growth Opportunity, by Distribution Channel, 2024 – 2032 68
10.1.4. Venous Thromboembolism (VTE) Treatment Market Revenue, By Distribution Channel, 2018, 2023, 2027 & 2032 69
10.2. Hospital Pharmacy 70
10.3. Retail Pharmacy 71
10.4. Online Pharmacy 72
10.5. Others 73
CHAPTER NO. 11 : VENOUS THROMBOEMBOLISM (VTE) TREATMENT MARKET – GLOBAL ANALYSIS 74
11.1. Type 74
11.1.1. Global Venous Thromboembolism (VTE) Treatment Market Revenue, By Type, 2018 – 2023 (USD Million) 74
11.2. Global Venous Thromboembolism (VTE) Treatment Market Revenue, By Type, 2024 – 2032 (USD Million) 74
11.3. Treatment 75
11.3.1. Global Venous Thromboembolism (VTE) Treatment Market Revenue, By Treatment, 2018 – 2023 (USD Million) 75
11.3.2. Global Venous Thromboembolism (VTE) Treatment Market Revenue, By Treatment, 2024 – 2032 (USD Million) 75
11.4. End-user 76
11.4.1. Global Venous Thromboembolism (VTE) Treatment Market Revenue, By End-user, 2018 – 2023 (USD Million) 76
11.4.2. Global Venous Thromboembolism (VTE) Treatment Market Revenue, By End-user, 2024 – 2032 (USD Million) 76
11.5. Distribution Channel 77
11.5.1. Global Venous Thromboembolism (VTE) Treatment Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 77
11.5.2. Global Venous Thromboembolism (VTE) Treatment Market Revenue, By Distribution Channel, 2024 – 2032 (USD Million) 77
CHAPTER NO. 12 : VENOUS THROMBOEMBOLISM (VTE) TREATMENT MARKET – NORTH AMERICA 78
12.1. North America 78
12.1.1. Key Highlights 78
12.1.2. North America Venous Thromboembolism (VTE) Treatment Market Revenue, By Country, 2018 – 2023 (USD Million) 79
12.1.3. North America Venous Thromboembolism (VTE) Treatment Market Revenue, By Type, 2018 – 2023 (USD Million) 80
12.1.4. North America Venous Thromboembolism (VTE) Treatment Market Revenue, By Treatment, 2018 – 2023 (USD Million) 81
12.1.5. North America Venous Thromboembolism (VTE) Treatment Market Revenue, By End-user, 2018 – 2023 (USD Million) 82
12.1.6. North America Venous Thromboembolism (VTE) Treatment Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 83
12.2. U.S. 84
12.3. Canada 84
12.4. Mexico 84
CHAPTER NO. 13 : VENOUS THROMBOEMBOLISM (VTE) TREATMENT MARKET – EUROPE 85
13.1. Europe 85
13.1.1. Key Highlights 85
13.1.2. Europe Venous Thromboembolism (VTE) Treatment Market Revenue, By Country, 2018 – 2023 (USD Million) 86
13.1.3. Europe Venous Thromboembolism (VTE) Treatment Market Revenue, By Type, 2018 – 2023 (USD Million) 87
13.1.4. Europe Venous Thromboembolism (VTE) Treatment Market Revenue, By Treatment, 2018 – 2023 (USD Million) 88
13.1.5. Europe Venous Thromboembolism (VTE) Treatment Market Revenue, By End-user, 2018 – 2023 (USD Million) 89
13.1.6. Europe Venous Thromboembolism (VTE) Treatment Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 90
13.2. UK 91
13.3. France 91
13.4. Germany 91
13.5. Italy 91
13.6. Spain 91
13.7. Russia 91
13.8. Belgium 91
13.9. Netherland 91
13.10. Austria 91
13.11. Sweden 91
13.12. Poland 91
13.13. Denmark 91
13.14. Switzerland 91
13.15. Rest of Europe 91
CHAPTER NO. 14 : VENOUS THROMBOEMBOLISM (VTE) TREATMENT MARKET – ASIA PACIFIC 92
14.1. Asia Pacific 92
14.1.1. Key Highlights 92
14.1.2. Asia Pacific Venous Thromboembolism (VTE) Treatment Market Revenue, By Country, 2018 – 2023 (USD Million) 93
14.1.3. Asia Pacific Venous Thromboembolism (VTE) Treatment Market Revenue, By Type, 2018 – 2023 (USD Million) 94
14.1.4. Asia Pacific Venous Thromboembolism (VTE) Treatment Market Revenue, By Treatment, 2018 – 2023 (USD Million) 95
14.1.5. Asia Pacific Venous Thromboembolism (VTE) Treatment Market Revenue, By End-user, 2018 – 2023 (USD Million) 96
14.1.6. Asia Pacific Venous Thromboembolism (VTE) Treatment Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 97
14.2. China 98
14.3. Japan 98
14.4. South Korea 98
14.5. India 98
14.6. Australia 98
14.7. Thailand 98
14.8. Indonesia 98
14.9. Vietnam 98
14.10. Malaysia 98
14.11. Philippines 98
14.12. Taiwan 98
14.13. Rest of Asia Pacific 98
CHAPTER NO. 15 : VENOUS THROMBOEMBOLISM (VTE) TREATMENT MARKET – LATIN AMERICA 99
15.1. Latin America 99
15.1.1. Key Highlights 99
15.1.2. Latin America Venous Thromboembolism (VTE) Treatment Market Revenue, By Country, 2018 – 2023 (USD Million) 100
15.1.3. Latin America Venous Thromboembolism (VTE) Treatment Market Revenue, By Type, 2018 – 2023 (USD Million) 101
15.1.4. Latin America Venous Thromboembolism (VTE) Treatment Market Revenue, By Treatment, 2018 – 2023 (USD Million) 102
15.1.5. Latin America Venous Thromboembolism (VTE) Treatment Market Revenue, By End-user, 2018 – 2023 (USD Million) 103
15.1.6. Latin America Venous Thromboembolism (VTE) Treatment Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 104
15.2. Brazil 105
15.3. Argentina 105
15.4. Peru 105
15.5. Chile 105
15.6. Colombia 105
15.7. Rest of Latin America 105
CHAPTER NO. 16 : VENOUS THROMBOEMBOLISM (VTE) TREATMENT MARKET – MIDDLE EAST 106
16.1. Middle East 106
16.1.1. Key Highlights 106
16.1.2. Middle East Venous Thromboembolism (VTE) Treatment Market Revenue, By Country, 2018 – 2023 (USD Million) 107
16.1.3. Middle East Venous Thromboembolism (VTE) Treatment Market Revenue, By Type, 2018 – 2023 (USD Million) 108
16.1.4. Middle East Venous Thromboembolism (VTE) Treatment Market Revenue, By Treatment, 2018 – 2023 (USD Million) 109
16.1.5. Middle East Venous Thromboembolism (VTE) Treatment Market Revenue, By End-user, 2018 – 2023 (USD Million) 110
16.1.6. Middle East Venous Thromboembolism (VTE) Treatment Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 111
16.2. UAE 112
16.3. KSA 112
16.4. Israel 112
16.5. Turkey 112
16.6. Iran 112
16.7. Rest of Middle East 112
CHAPTER NO. 17 : VENOUS THROMBOEMBOLISM (VTE) TREATMENT MARKET – AFRICA 113
17.1. Africa 113
17.1.1. Key Highlights 113
17.1.2. Africa Venous Thromboembolism (VTE) Treatment Market Revenue, By Country, 2018 – 2023 (USD Million) 114
17.1.3. Africa Venous Thromboembolism (VTE) Treatment Market Revenue, By Type, 2018 – 2023 (USD Million) 115
17.1.4. Africa Venous Thromboembolism (VTE) Treatment Market Revenue, By Treatment, 2018 – 2023 (USD Million) 116
17.1.5. Africa Venous Thromboembolism (VTE) Treatment Market Revenue, By End-user, 2018 – 2023 (USD Million) 117
17.1.6. Africa Venous Thromboembolism (VTE) Treatment Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 118
17.2. Egypt 119
17.3. Nigeria 119
17.4. Algeria 119
17.5. Morocco 119
17.6. Rest of Africa 119
CHAPTER NO. 18 : COMPANY PROFILES 120
18.1. Boehringer Ingelheim 120
18.1.1. Company Overview 120
18.1.2. Product Portfolio 120
18.1.3. Swot Analysis 120
18.1.4. Business Strategy 121
18.1.5. Financial Overview 121
18.2. Bayer 122
18.3. Janssen 122
18.4. Arjo 122
18.5. DJO Global 122
18.6. ALN Impiants chirurgicaux (ALN Surgical Implants) 122
18.7. Bristol-Myers Squibb 122
18.8. Pfizer 122
18.9. Daiichi-Sankyo 122
18.10. Portola 122
18.11. Stryker Corporation 122
18.12. AngioDynamics, Inc. 122
18.13. Enovis Corporation 122
18.14. LifeTech Scientific Corporation 122
18.15. Medtronic pic 122
18.16. Argon Medical Devices 122
18.17. Cardinal Health (Medtronic) 122
18.18. Cook Medical 122
18.19. Boston Scientific Corporation 122
18.20. Koninklijke Philips N.V. 122
CHAPTER NO. 19 : RESEARCH METHODOLOGY 123
19.1. Research Methodology 123
19.1.1. Phase I – Secondary Research 124
19.1.2. Phase II – Data Modeling 124
Company Share Analysis Model 125
Revenue Based Modeling 125
19.1.3. Phase III – Primary Research 126
19.1.4. Research Limitations 127
Assumptions 127
List of Figures
FIG NO. 1. Global Venous Thromboembolism (VTE) Treatment Market Revenue, 2018 – 2032 (USD Million) 26
FIG NO. 2. Porter’s Five Forces Analysis for Global Venous Thromboembolism (VTE) Treatment Market 33
FIG NO. 3. Company Share Analysis, 2023 34
FIG NO. 4. Company Share Analysis, 2023 35
FIG NO. 5. Company Share Analysis, 2023 35
FIG NO. 6. Company Share Analysis, 2023 36
FIG NO. 7. Venous Thromboembolism (VTE) Treatment Market – Company Volume Market Share, 2023 37
FIG NO. 8. Venous Thromboembolism (VTE) Treatment Market – Company Revenue Market Share, 2023 38
FIG NO. 9. Venous Thromboembolism (VTE) Treatment Market Revenue Share, By Type, 2023 & 2032 44
FIG NO. 10. Market Attractiveness Analysis, By Type 45
FIG NO. 11. Incremental Revenue Growth Opportunity by Type, 2024 – 2032 45
FIG NO. 12. Venous Thromboembolism (VTE) Treatment Market Revenue, By Type, 2018, 2023, 2027 & 2032 46
FIG NO. 13. Global Venous Thromboembolism (VTE) Treatment Market for Deep Vein Thrombosis, Revenue (USD Million) 2018 – 2032 47
FIG NO. 14. Global Venous Thromboembolism (VTE) Treatment Market for Pulmonary Embolism, Revenue (USD Million) 2018 – 2032 48
FIG NO. 15. Global Venous Thromboembolism (VTE) Treatment Market for Others, Revenue (USD Million) 2018 – 2032 49
FIG NO. 16. Venous Thromboembolism (VTE) Treatment Market Revenue Share, By Treatment, 2023 & 2032 51
FIG NO. 17. Market Attractiveness Analysis, By Treatment 52
FIG NO. 18. Incremental Revenue Growth Opportunity by Treatment, 2024 – 2032 52
FIG NO. 19. Venous Thromboembolism (VTE) Treatment Market Revenue, By Treatment, 2018, 2023, 2027 & 2032 53
FIG NO. 20. Global Venous Thromboembolism (VTE) Treatment Market for Mechanical Devices, Revenue (USD Million) 2018 – 2032 54
FIG NO. 21. Global Venous Thromboembolism (VTE) Treatment Market for Thrombolytic Therapy, Revenue (USD Million) 2018 – 2032 55
FIG NO. 22. Global Venous Thromboembolism (VTE) Treatment Market for Anti-Clotting Medications, Revenue (USD Million) 2018 – 2032 56
FIG NO. 23. Global Venous Thromboembolism (VTE) Treatment Market for Others, Revenue (USD Million) 2018 – 2032 57
FIG NO. 24. Venous Thromboembolism (VTE) Treatment Market Revenue Share, By End-user, 2023 & 2032 59
FIG NO. 25. Market Attractiveness Analysis, By End-user 60
FIG NO. 26. Incremental Revenue Growth Opportunity by End-user, 2024 – 2032 60
FIG NO. 27. Venous Thromboembolism (VTE) Treatment Market Revenue, By End-user, 2018, 2023, 2027 & 2032 61
FIG NO. 28. Global Venous Thromboembolism (VTE) Treatment Market for Homecare, Revenue (USD Million) 2018 – 2032 62
FIG NO. 29. Global Venous Thromboembolism (VTE) Treatment Market for Speciality Centres, Revenue (USD Million) 2018 – 2032 63
FIG NO. 30. Global Venous Thromboembolism (VTE) Treatment Market for Hospitals, Revenue (USD Million) 2018 – 2032 64
FIG NO. 31. Global Venous Thromboembolism (VTE) Treatment Market for Others, Revenue (USD Million) 2018 – 2032 65
FIG NO. 32. Venous Thromboembolism (VTE) Treatment Market Revenue Share, By Distribution Channel, 2023 & 2032 67
FIG NO. 33. Market Attractiveness Analysis, By Distribution Channel 68
FIG NO. 34. Incremental Revenue Growth Opportunity by Distribution Channel, 2024 – 2032 68
FIG NO. 35. Venous Thromboembolism (VTE) Treatment Market Revenue, By Distribution Channel, 2018, 2023, 2027 & 2032 69
FIG NO. 36. Global Venous Thromboembolism (VTE) Treatment Market for Hospital Pharmacy, Revenue (USD Million) 2018 – 2032 70
FIG NO. 37. Global Venous Thromboembolism (VTE) Treatment Market for Retail Pharmacy, Revenue (USD Million) 2018 – 2032 71
FIG NO. 38. Global Venous Thromboembolism (VTE) Treatment Market for Online Pharmacy, Revenue (USD Million) 2018 – 2032 72
FIG NO. 39. Global Venous Thromboembolism (VTE) Treatment Market for Others, Revenue (USD Million) 2018 – 2032 73
FIG NO. 40. North America Venous Thromboembolism (VTE) Treatment Market Revenue, 2018 – 2032 (USD Million) 78
FIG NO. 41. Europe Venous Thromboembolism (VTE) Treatment Market Revenue, 2018 – 2032 (USD Million) 85
FIG NO. 42. Asia Pacific Venous Thromboembolism (VTE) Treatment Market Revenue, 2018 – 2032 (USD Million) 92
FIG NO. 43. Latin America Venous Thromboembolism (VTE) Treatment Market Revenue, 2018 – 2032 (USD Million) 99
FIG NO. 44. Middle East Venous Thromboembolism (VTE) Treatment Market Revenue, 2018 – 2032 (USD Million) 106
FIG NO. 45. Africa Venous Thromboembolism (VTE) Treatment Market Revenue, 2018 – 2032 (USD Million) 113
FIG NO. 46. Research Methodology – Detailed View 123
FIG NO. 47. Research Methodology 124
List of Tables
TABLE NO. 1. : Global Venous Thromboembolism (VTE) Treatment Market: Snapshot 24
TABLE NO. 2. : Drivers for the Venous Thromboembolism (VTE) Treatment Market: Impact Analysis 29
TABLE NO. 3. : Restraints for the Venous Thromboembolism (VTE) Treatment Market: Impact Analysis 31
TABLE NO. 4. : Global Venous Thromboembolism (VTE) Treatment Market Revenue, By Type, 2018 – 2023 (USD Million) 74
TABLE NO. 5. : Global Venous Thromboembolism (VTE) Treatment Market Revenue, By Type, 2024 – 2032 (USD Million) 74
TABLE NO. 6. : Global Venous Thromboembolism (VTE) Treatment Market Revenue, By Treatment, 2018 – 2023 (USD Million) 75
TABLE NO. 7. : Global Venous Thromboembolism (VTE) Treatment Market Revenue, By Treatment, 2024 – 2032 (USD Million) 75
TABLE NO. 8. : Global Venous Thromboembolism (VTE) Treatment Market Revenue, By End-user, 2018 – 2023 (USD Million) 76
TABLE NO. 9. : Global Venous Thromboembolism (VTE) Treatment Market Revenue, By End-user, 2024 – 2032 (USD Million) 76
TABLE NO. 10. : Global Venous Thromboembolism (VTE) Treatment Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 77
TABLE NO. 11. : Global Venous Thromboembolism (VTE) Treatment Market Revenue, By Distribution Channel, 2024 – 2032 (USD Million) 77
TABLE NO. 12. : North America Venous Thromboembolism (VTE) Treatment Market Revenue, By Country, 2018 – 2023 (USD Million) 79
TABLE NO. 13. : North America Venous Thromboembolism (VTE) Treatment Market Revenue, By Country, 2024 – 2032 (USD Million) 79
TABLE NO. 14. : North America Venous Thromboembolism (VTE) Treatment Market Revenue, By Type, 2018 – 2023 (USD Million) 80
TABLE NO. 15. : North America Venous Thromboembolism (VTE) Treatment Market Revenue, By Type, 2024 – 2032 (USD Million) 80
TABLE NO. 16. : North America Venous Thromboembolism (VTE) Treatment Market Revenue, By Treatment, 2018 – 2023 (USD Million) 81
TABLE NO. 17. : North America Venous Thromboembolism (VTE) Treatment Market Revenue, By Treatment, 2024 – 2032 (USD Million) 81
TABLE NO. 18. : North America Venous Thromboembolism (VTE) Treatment Market Revenue, By End-user, 2018 – 2023 (USD Million) 82
TABLE NO. 19. : North America Venous Thromboembolism (VTE) Treatment Market Revenue, By End-user, 2024 – 2032 (USD Million) 82
TABLE NO. 20. : North America Venous Thromboembolism (VTE) Treatment Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 83
TABLE NO. 21. : North America Venous Thromboembolism (VTE) Treatment Market Revenue, By Distribution Channel, 2024 – 2032 (USD Million) 83
TABLE NO. 22. : Europe Venous Thromboembolism (VTE) Treatment Market Revenue, By Country, 2018 – 2023 (USD Million) 86
TABLE NO. 23. : Europe Venous Thromboembolism (VTE) Treatment Market Revenue, By Country, 2024 – 2032 (USD Million) 86
TABLE NO. 24. : Europe Venous Thromboembolism (VTE) Treatment Market Revenue, By Type, 2018 – 2023 (USD Million) 87
TABLE NO. 25. : Europe Venous Thromboembolism (VTE) Treatment Market Revenue, By Type, 2024 – 2032 (USD Million) 87
TABLE NO. 26. : Europe Venous Thromboembolism (VTE) Treatment Market Revenue, By Treatment, 2018 – 2023 (USD Million) 88
TABLE NO. 27. : Europe Venous Thromboembolism (VTE) Treatment Market Revenue, By Treatment, 2024 – 2032 (USD Million) 88
TABLE NO. 28. : Europe Venous Thromboembolism (VTE) Treatment Market Revenue, By End-user, 2018 – 2023 (USD Million) 89
TABLE NO. 29. : Europe Venous Thromboembolism (VTE) Treatment Market Revenue, By End-user, 2024 – 2032 (USD Million) 89
TABLE NO. 30. : Europe Venous Thromboembolism (VTE) Treatment Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 90
TABLE NO. 31. : Europe Venous Thromboembolism (VTE) Treatment Market Revenue, By Distribution Channel, 2024 – 2032 (USD Million) 90
TABLE NO. 32. : Asia Pacific Venous Thromboembolism (VTE) Treatment Market Revenue, By Country, 2018 – 2023 (USD Million) 93
TABLE NO. 33. : Asia Pacific Venous Thromboembolism (VTE) Treatment Market Revenue, By Country, 2024 – 2032 (USD Million) 93
TABLE NO. 34. : Asia Pacific Venous Thromboembolism (VTE) Treatment Market Revenue, By Type, 2018 – 2023 (USD Million) 94
TABLE NO. 35. : Asia Pacific Venous Thromboembolism (VTE) Treatment Market Revenue, By Type, 2024 – 2032 (USD Million) 94
TABLE NO. 36. : Asia Pacific Venous Thromboembolism (VTE) Treatment Market Revenue, By Treatment, 2018 – 2023 (USD Million) 95
TABLE NO. 37. : Asia Pacific Venous Thromboembolism (VTE) Treatment Market Revenue, By Treatment, 2024 – 2032 (USD Million) 95
TABLE NO. 38. : Asia Pacific Venous Thromboembolism (VTE) Treatment Market Revenue, By End-user, 2018 – 2023 (USD Million) 96
TABLE NO. 39. : Asia Pacific Venous Thromboembolism (VTE) Treatment Market Revenue, By End-user, 2024 – 2032 (USD Million) 96
TABLE NO. 40. : Asia Pacific Venous Thromboembolism (VTE) Treatment Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 97
TABLE NO. 41. : Asia Pacific Venous Thromboembolism (VTE) Treatment Market Revenue, By Distribution Channel, 2024 – 2032 (USD Million) 97
TABLE NO. 42. : Latin America Venous Thromboembolism (VTE) Treatment Market Revenue, By Country, 2018 – 2023 (USD Million) 100
TABLE NO. 43. : Latin America Venous Thromboembolism (VTE) Treatment Market Revenue, By Country, 2024 – 2032 (USD Million) 100
TABLE NO. 44. : Latin America Venous Thromboembolism (VTE) Treatment Market Revenue, By Type, 2018 – 2023 (USD Million) 101
TABLE NO. 45. : Latin America Venous Thromboembolism (VTE) Treatment Market Revenue, By Type, 2024 – 2032 (USD Million) 101
TABLE NO. 46. : Latin America Venous Thromboembolism (VTE) Treatment Market Revenue, By Treatment, 2018 – 2023 (USD Million) 102
TABLE NO. 47. : Latin America Venous Thromboembolism (VTE) Treatment Market Revenue, By Treatment, 2024 – 2032 (USD Million) 102
TABLE NO. 48. : Latin America Venous Thromboembolism (VTE) Treatment Market Revenue, By End-user, 2018 – 2023 (USD Million) 103
TABLE NO. 49. : Latin America Venous Thromboembolism (VTE) Treatment Market Revenue, By End-user, 2024 – 2032 (USD Million) 103
TABLE NO. 50. : Latin America Venous Thromboembolism (VTE) Treatment Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 104
TABLE NO. 51. : Latin America Venous Thromboembolism (VTE) Treatment Market Revenue, By Distribution Channel, 2024 – 2032 (USD Million) 104
TABLE NO. 52. : Middle East Venous Thromboembolism (VTE) Treatment Market Revenue, By Country, 2018 – 2023 (USD Million) 107
TABLE NO. 53. : Middle East Venous Thromboembolism (VTE) Treatment Market Revenue, By Country, 2024 – 2032 (USD Million) 107
TABLE NO. 54. : Middle East Venous Thromboembolism (VTE) Treatment Market Revenue, By Type, 2018 – 2023 (USD Million) 108
TABLE NO. 55. : Middle East Venous Thromboembolism (VTE) Treatment Market Revenue, By Type, 2024 – 2032 (USD Million) 108
TABLE NO. 56. : Middle East Venous Thromboembolism (VTE) Treatment Market Revenue, By Treatment, 2018 – 2023 (USD Million) 109
TABLE NO. 57. : Middle East Venous Thromboembolism (VTE) Treatment Market Revenue, By Treatment, 2024 – 2032 (USD Million) 109
TABLE NO. 58. : Middle East Venous Thromboembolism (VTE) Treatment Market Revenue, By End-user, 2018 – 2023 (USD Million) 110
TABLE NO. 59. : Middle East Venous Thromboembolism (VTE) Treatment Market Revenue, By End-user, 2024 – 2032 (USD Million) 110
TABLE NO. 60. : Middle East Venous Thromboembolism (VTE) Treatment Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 111
TABLE NO. 61. : Middle East Venous Thromboembolism (VTE) Treatment Market Revenue, By Distribution Channel, 2024 – 2032 (USD Million) 111
TABLE NO. 62. : Africa Venous Thromboembolism (VTE) Treatment Market Revenue, By Country, 2018 – 2023 (USD Million) 114
TABLE NO. 63. : Africa Venous Thromboembolism (VTE) Treatment Market Revenue, By Country, 2024 – 2032 (USD Million) 114
TABLE NO. 64. : Africa Venous Thromboembolism (VTE) Treatment Market Revenue, By Type, 2018 – 2023 (USD Million) 115
TABLE NO. 65. : Africa Venous Thromboembolism (VTE) Treatment Market Revenue, By Type, 2024 – 2032 (USD Million) 115
TABLE NO. 66. : Africa Venous Thromboembolism (VTE) Treatment Market Revenue, By Treatment, 2018 – 2023 (USD Million) 116
TABLE NO. 67. : Africa Venous Thromboembolism (VTE) Treatment Market Revenue, By Treatment, 2024 – 2032 (USD Million) 116
TABLE NO. 68. : Africa Venous Thromboembolism (VTE) Treatment Market Revenue, By End-user, 2018 – 2023 (USD Million) 117
TABLE NO. 69. : Africa Venous Thromboembolism (VTE) Treatment Market Revenue, By End-user, 2024 – 2032 (USD Million) 117
TABLE NO. 70. : Africa Venous Thromboembolism (VTE) Treatment Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 118
TABLE NO. 71. : Africa Venous Thromboembolism (VTE) Treatment Market Revenue, By Distribution Channel, 2024 – 2032 (USD Million) 118